SLC6A14 and cystic fibrosis: Di Paola et al. observed that primary cells from individuals with CF or healthy donors showed a similar mRNA level for SLC6A14 [17], suggesting that CFTR pathogenic variants had no impact on SLC6A14 mRNA expression.